Published on in Vol 10, No 4 (2022): April

Preprints (earlier versions) of this paper are available at, first published .
A Mobile Phone App to Support Adherence to Daily HIV Pre-exposure Prophylaxis Engagement Among Young Men Who Have Sex With Men and Transgender Women Aged 15 to 19 Years in Thailand: Pilot Randomized Controlled Trial

A Mobile Phone App to Support Adherence to Daily HIV Pre-exposure Prophylaxis Engagement Among Young Men Who Have Sex With Men and Transgender Women Aged 15 to 19 Years in Thailand: Pilot Randomized Controlled Trial

A Mobile Phone App to Support Adherence to Daily HIV Pre-exposure Prophylaxis Engagement Among Young Men Who Have Sex With Men and Transgender Women Aged 15 to 19 Years in Thailand: Pilot Randomized Controlled Trial

Original Paper

1Center of Excellence for Pediatric Infectious Diseases and Vaccines, Chulalongkorn University, Bangkok, Thailand

2Center of Excellence in Transgender Health, Chulalongkorn University, Bangkok, Thailand

3Institute of HIV Research and Innovation, Bangkok, Thailand

4The Program for HIV Prevention and Treatment/ Unité Mixte de recherches Internationale 174, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand

5Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom

6Focal Intelligence Co Ltd, Bangkok, Thailand

7Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand

Corresponding Author:

Wipaporn Natalie Songtaweesin, MBBS, DTMH

Center of Excellence in Transgender Health

Chulalongkorn University

King Chulalongkorn Memorial Hospital

1873 Rama 4 Rd, Patumwan

Bangkok, 10330


Phone: 66 22564930


Background: Widespread smartphone use provides opportunities for mobile health HIV prevention strategies among at-risk populations.

Objective: This study aims to investigate engagement in a theory-based (information–motivation–behavioral skills model) mobile phone app developed to support HIV pre-exposure prophylaxis (PrEP) adherence among Thai young men who have sex with men (YMSM) and young transgender women (YTGW) in Bangkok, Thailand.

Methods: A randomized controlled trial was conducted among HIV-negative YMSM and YTGW aged 15-19 years initiating daily oral PrEP. Participants were randomized to receive either youth-friendly PrEP services (YFS) for 6 months, including monthly contact with site staff (clinic visits or telephone follow-up) and staff consultation access, or YFS plus use of a PrEP adherence support app (YFS+APP). The target population focus group discussion findings and the information–motivation–behavioral skills model informed app development. App features were based on the 3Rs—risk assessment of self-HIV acquisition risk, reminders to take PrEP, and rewards as redeemable points. Dried blood spots quantifying of tenofovir diphosphate were collected at months 3 and 6 to assess PrEP adherence. Tenofovir diphosphate ≥350-699 fmol/punch was classified as fair adherence and ≥700 fmol/punch as good adherence. Data analysis on app use paradata and exit interviews were conducted on the YFS+APP arm after 6 months of follow-up.

Results: Between March 2018 and June 2019, 200 participants with a median age of 18 (IQR 17-19) years were enrolled. Overall, 74% (148/200) were YMSM; 87% (87/100) of participants who received YFS+APP logged in to the app and performed weekly HIV acquisition risk assessments (log-in and risk assessment [LRA]). The median duration between the first and last log-in was 3.5 (IQR 1.6-5.6) months, with a median frequency of 6 LRAs (IQR 2-10). Moreover, 22% (22/100) of the participants in the YFS+APP arm were frequent users (LRA≥10) during the 6-month follow-up period. YMSM were 9.3 (95% CI 1.2-74.3) times more likely to be frequent app users than YTGW (P=.04). Frequent app users had higher proportions (12%-16%) of PrEP adherence at both months 3 and 6 compared with infrequent users (LRA<10) and the YFS arm, although this did not reach statistical significance. Of the 100 participants in the YFS+APP arm, 23 (23%) were interviewed. The risk assessment function is perceived as the most useful app feature. Further aesthetic adaptations and a more comprehensive rewards system were suggested by the interviewees.

Conclusions: Higher rates of PrEP adherence among frequent app users were observed; however, this was not statistically significant. A short app use duration of 3 months suggests that they may be useful in establishing habits in taking daily PrEP, but not long-term adherence. Further studies on the specific mechanisms of mobile phone apps that influence health behaviors are needed.

Trial Registration: NCT03778892;

JMIR Mhealth Uhealth 2022;10(4):e25561




The emergence of advanced technologies and widespread use of smartphones provides opportunities for new HIV research and prevention strategies using mobile health (mHealth) within high-risk populations [1,2]. mHealth is the practice of medical and public health supported by mobile devices, such as mobile phones, patient monitoring devices, PDAs, and other wireless devices [3]. Data on user interaction with web-based intervention tools are readily available as part of such technologies and form useful surrogate markers of user engagement characteristics [4]. Despite the high potential for mHealth use in service delivery, there is a lack of data on how this is best delivered in low- and middle-income countries and in youth [1,2].

Men who have sex with men (MSM) and transgender women (TGW) are at high risk for HIV infection globally [5]. In Thailand, over 80% of new infections occur in this population [6], with young MSM (YMSM) and young transgender women (YTGW) at even greater risk than their older counterparts [7,8], as HIV incidence among YMSM and YTGW is 4-12 per 100 person-years [9-13], well above the 3 per 100 person-years World Health Organization incidence recommendation priority for offering HIV pre-exposure prophylaxis (PrEP) [14].

With the safety and effectiveness of PrEP established [14-18], the current challenge with PrEP is how best it can be implemented in key populations. The use of PrEP to prevent HIV has been recommended in the Thai national guidelines since 2014 [19], initially available as a fee-based PrEP the same year and also the following year through PrEP demonstration projects in 2015. The Princess PrEP Project, a key population-led PrEP service delivered to MSM and TGW by lay providers, was launched in 2016, contributing to 60% of all national PrEP uptakes [20,21]. PrEP2start was then launched by the Thai Ministry of Public Health in 2017, a nationwide scale-up initiative to increase accessibility to PrEP for key populations, including TGW and MSM [22]. Most recently, in 2019, PrEP became available under Thailand’s Universal Health Coverage Scheme [21].

Given that PrEP efficacy is highly reliant on adherence [23], strategies to support adherence, encompassing those from biological, psychological, and social fronts, are key to its effectiveness at the public health level [24-27]. PrEP adherence in adolescents is known to be a challenge with adherence observed at 28% to 48% after 6 months of use, and it has been acknowledged that tailored approaches for this key population are needed to deliver effective prevention programs [25-28]. mHealth has been implemented in managing various health behaviors in adolescents, including sexual health promotion, disease prevention, antiretroviral adherence in HIV, and emotional health support, and outcomes have been promising [29,30]. A pilot mHealth study, iText, to support PrEP adherence motivation using weekly SMS text or email support messaging, found that it was acceptable, particularly among young participants, and demonstrated a 50% to 77% reduction in missed PrEP dosing with its use [31]. There is currently a lack of data evaluating eHealth service delivery strategies from low- to middle-income countries to support HIV prevention efforts [1,30,32]. Mobile phone health apps that use bidirectional interactions and are designed based on behavioral theories have been found to be more effective in influencing health behaviors than those that send unidirectional messages [2]. A frequently used theory in mobile app design is the information–motivation–behavioral (IMB) skills model that asserts that initiation and maintenance of health-promoting behaviors come about as a result of a combination of health-related IMB skills [2,33].


Our aim in this study is to investigate participant engagement and the impact on PrEP adherence of the Project Raincoat mobile phone app, which was based on the IMB skills model developed to support PrEP adherence among YMSM and YTGW at risk of HIV acquisition, in the context of an adolescent-friendly clinic providing bidirectional web-based communications in Thailand. The primary results of this trial showed no difference in measured PrEP adherence between arms that received the app and those that did not; approximately 50% of all PrEP users achieved protective drug levels and no seroconversions were observed [33].

Overview and Ethical Considerations

This was a prospective randomized controlled trial of oral daily PrEP in youth at risk of HIV acquisition in Bangkok, Thailand [34]. Adolescents aged 15-19 years, assigned male gender at birth, and self-defining as MSM or TGW with HIV risk acquisition behaviors, defined as having >1 sex partner and inconsistent or no condom use in the preceding 6 months were included in this study. Participants could be new, current, or former PrEP users. They were randomized (1:1) to receive oral daily tenofovir-disoproxil fumarate/emtricitabine provided by either youth-friendly services (YFS) only or YFS plus the use of the Raincoat app (YFS+APP). This study was conducted in two different settings: (1) medical center–based facilities at the Thai Red Cross AIDS Research Center (TRCARC), the largest voluntary HIV testing center of Thailand, and the King Chulalongkorn Memorial Hospital, a major teaching hospital in Bangkok and (2) key population-led community-based drop-in centers operating as satellite sites of TRCARC, namely, the Rainbow Sky Association of Thailand (RSAT) and Service Workers In Group (SWING), both located in Bangkok, Thailand. Care at the 2 different medical center–based facilities was performed by the same team that moved between the 2 locations and tended to receive clients slightly more medically informed than those in the community-based drop-in centers. RSAT, owing to its proximity to universities and nearby student accommodation, received proportionally more cases than SWING; however, staff at both RSAT and SWING delivered similar care, with both teams receiving training from TRCARC and our study team on standard operating procedures.

The institutional review board approval was granted by the Faculty of Medicine, Chulalongkorn University (number 1091/2017), with a waiver for parental consent. This study was registered with (NCT03778892).

Youth-Friendly Services

YFS included the following: (1) monthly engagement via either in-person clinic visits (months 1, 3, and 6) or telephone calls (months 2, 4, and 5) and (2) access to counselors and site staff outside scheduled visits through web-based messaging or telephone calls with responses provided within 24 hours. Clinic visits were available during weekdays and Saturday mornings to accommodate adolescent lifestyles. Motivational interviewing focused on HIV risk reduction and empowerment on using available HIV prevention methods was used by counselors during all interactions with clients [35,36].

Mobile Phone App Development and Use

The Raincoat mobile app was developed in conjunction with Focal Intelligence Co. Ltd. and designed using the IMB skills model guided by input from two adolescent focus group discussions (FGDs), one with 3 MSM and one with 3 TGW, all aged between 15 and 19 years [37,38]. Discussions were conducted using a semistructured interview guide with topics on desirable app functions, aesthetic preferences, potential barriers, and motivators for use. Key themes and subthemes were identified from content analysis, which then informed app design. The app prototype was tested with staff providing HIV prevention care to clients at all study sites (2 from each site, totaling 8 usability testers) whose feedback was used to inform the final app design.

The final app designed had three main features, which we refer to as the 3Rs: risk assessment, reminders, and rewards. The former addresses the information component of the IMB model, and the latter two address the motivation component, with further explanation as follows: (1) risk: self-assessment of HIV acquisition risk with a once-weekly data input portal on the number of sex acts, sex partners, PrEP pills taken, and condom use, which was then used to calculate a feedback HIV risk level of low, medium, high, and very high; (2) reminders: in-built alarms for taking PrEP and HIV risk self-assessment using default set messages that were customizable; and (3) rewards: points were rewarded in real time for data input (maximum reward of 21 points per week) as well as to responding to staff follow-up calls (5 points each), attendance of clinic visits (10 points each), and negative anti-HIV test results (50 points each). Points rewarded were part of the intervention and were available to the YFS+APP arm only. Points were exchangeable for cash, with redemption being available at every 100 points if redeemed before the end of the study. Moreover, 100 points were exchangeable for ฿100 (US $3) at month 3 or month 6 clinic visits. A maximum of 719 points could be accumulated when using the app for 6 months.

The app was available only on the Android operating system. Android mobile phones were available for loans to those using other operating systems. Participants were free to log in to the app at any time. Staff provided guidance at their enrollment visit on how to load the app and introduced its functions. Participants required an email for initial registration and were asked to create their own usernames and passwords. Usernames and passwords were required for each log-in to ensure confidentiality. If participants had any issues using the app, they were free to contact the staff to resolve them. Customizable medication reminder messages could be created and changed at any time. The app was accessible offline for all features apart from the self-risk assessment feature, which could only be used with internet connectivity.

Mobile App Users—Exit Interviews

To solicit the attitudes of users toward the app, exit interviews were conducted using open-ended questions. Using convenience sampling, we interviewed a selection of participants who had (1) never logged in to the app, (2) used the app infrequently (defined as performance of log-in and risk assessment [LRA] of 1-9 times throughout the trial), and (3) been frequent users (defined as LRA≥10 times throughout the trial), with at least 10% of the total interviewees sampled from each group. Interview topics included facilitators and barriers to app use, valuable features of the app, reasons for nonuse, and general suggestions for improvement.

Study Procedures and Follow-up of PrEP Services

Follow-up clinic visits occurred at months 1, 3, and 6, and telephone contact was made at months 2, 4, and 5. Risk behaviors and risk perception surveys were conducted for each monthly contact.

Substance use information was collected from self-reported surveys completed by participants privately via an electronic form consisting of alcohol, sildenafil citrate, and other recreational drugs (eg, amphetamines, methamphetamines, ketamine, poppers [volatile alkyl nitrates], and marijuana). HIV blood testing was performed at baseline and at months 1, 3, and 6.

Biological Measurement of PrEP Adherence

Dried blood spots (DBSs) were collected for quantification of tenofovir diphosphate (TFV-DP) concentrations at months 3 and 6 of follow-up. Whole blood samples were collected on Whatman Protein Saver 903 cards. DBSs were stored at −70 °C until analysis. TFV-DP was analyzed by liquid chromatography mass spectrometry. The TFV-DP calibration curve range was 200-10,000 fmol/3 mm punch [23,39] performed at the Program for HIV Prevention and Treatment Research Institute for Sustainable Development Pharmacology Laboratory at the Faculty of Associated Medical Sciences, Chiang Mai University. Details of the study methods have been previously published [34].

Statistical Analysis

Data on app use were downloaded for analysis after 6 months of follow-up. App paradata collected included first and last log-in dates, number of times logged in, number of LRAs, use of reminder messages, use of the medication alarm function, and total points accumulated.

The number of LRAs was used as an independent variable to assess user engagement with the app. TFV-DP DBS concentrations were used to evaluate PrEP adherence, with TFV-DP levels ≥700 fmol/punch considered good adherence (equivalent to ≥4 tablets/week) [23].

Continuous variables were presented as means with SDs or medians with IQRs, and categorical variables with absolute numbers and percentages. The chi-square test, Z test, Fisher exact test, odds ratios, and 95% CIs were used for group comparisons and associations as appropriate. Stata/SE (version 13.0; StataCorp) was used for quantitative data analyses.


Details of baseline characteristics and comparisons between the control arm (YFS) and the intervention arm (YFS+APP) have previously been published [34]. In brief, between March 2018 and June 2019, 200 HIV-negative participants were enrolled, 100 received YFS and 100 YFS+APP. The median age at enrollment was 18 (IQR 17-19) years, with 73.5% (147/200) self-defining as YMSM and 26.5% (53/200) as YTGW. Participants were enrolled and followed-up at medical center–based facilities (135/200, 67.5%) or community-based drop-in centers (65/200, 32.5%). Baseline characteristics between the YFS and YFS+APP arms were similar except for self-reported substance use in the preceding 3 months, which was higher in the YFS+APP arm, 18% (18/100), than in the YFS arm, 8% (8/100; P=.04) [34]. Of the 143 adolescents reporting sexual activity in the past month, 94 (65.7%) reported inconsistent condom use. Of the 200 participants, 187 (93.5%) rated themselves as having a low risk of HIV acquisition. There were no significant differences in PrEP adherence between the YFS and YFS+APP arms. PrEP adherence was 51% (40/79) in the YFS arm and 54% (44/81) in the YFS+APP arm (P=.64) at month 3 and was 44% (30/68) in the YFS arm and 49% (36/73) in the YFS+APP arm (P=.54) at month 6, further details of which have previously been published [34].

Risk Assessments

Of the 100 participants randomized to receive YFS+APP, 87 (87%) used LRA at least once during the follow-up period. Of these 87 app users, 55 (63%) used their own phones, and the remaining used loaned Android operating system phones. Of the 13 participants who never logged into the app, 10 (77%) used their own phones and 3 (23%) used loaned phones. Among the app users, the median (IQR) duration between the first and last LRA was 3.5 (1.6-5.6) months, with a median LRA frequency of 6 (IQR 2-10). There was no difference in median LRA frequency between participants who used their phones and those who used loaned phones (P=.21). The percentage of participants who used LRA declined over time, that is, 77%, 52%, and 28% at 2, 6, and 12 weeks after enrollment, respectively (Figure 1).

Of the 87 app users, 65 (76%) were infrequent users (LRA<10). Associations of LRA frequency and baseline characteristics among app users were assessed, and only gender identity was significantly associated with LRA, with YMSM 9.3 times (95% CI 1.2-74.3; P=.04) more likely to be frequent users than YTGW, but with a very wide CI (Table 1).

Associations between LRA frequency and PrEP adherence determined by TFV-DP DBS levels at months 3 and 6 are shown in Table 2.

Figure 1. Percentage of participants who logged in and performed risk assessments by week after enrollment (N=87).
View this figure
Table 1. Baseline characteristics of participants in the YFS+APPa arm who logged in to the mobile phone app and performed risk assessment (LRAb) at least once during the trial follow-up period and associations with LRA.
Demographic characteristicsTotal (n=87), n (%)LRA≥10 times, n (% by characteristics)ORc (95% CI)P value
Gender identity

MSMd66 (75)21 (31.8)9.3 (1.2-74.3).04

TGWe21 (24)1 (4.8)1N/Af
Age at enrollment (years)

15-1729 (33)6 (20.7)1N/A

18-1958 (66)16 (27.6)1.5 (0.5-4.2).49
Number of sex partner or partners in the last month

025 (28)8 (32)1N/A

138 (43)12 (31.5)1.0 (0.3-2.9).97

≥224 (27)2 (8.3)0.2 (0.0-1.0).05
Condom use in the past month among participants reporting sexual activity (n=62)

10018 (29)4 (22.2)1N/A

<10044 (71)10 (22.7)1.0 (0.3-3.8).97
Recreational substance use in the past 3 months (n=62)

No70 (80)19 (27.1)1N/A

Yes17 (19)3 (17.6)0.6 (0.2-2.2).42
Self-perceived risk (n=62)

Low or moderate risk52 (59)16 (30.8)1N/A

High risk35 (40)6 (17.1)0.5 (0.2-1.34).16

aYFS+APP: youth-focused strategies plus mobile phone app.

bLRA: log-in and risk assessment.

cOR: odds ratio.

dMSM: men who have sex with men.

eTGW: transgender women.

fN/A: not applicable (reference).

Table 2. Associations of Raincoat mobile phone app use and HIV PrEPa adherence (tenofovir diphosphate level ≥700 fmol/punch) at months 3 and 6.
App usersPrEP adherent, n (%; 95% CI)UnadjustedAdjustedb

Odds ratio (95% CI)P valueOdds ratioc (95% CI)P value
At 3 months

YFSd only (n=79)40 (50; 39.6-61.6)1.0N/AeN/AN/A

YFS and infrequent app use (n=53)29 (55; 41.3-68.1)1.8 (0.6-2.4).641.1 (0.5-2.4).84

YFS and frequent app use (n=21)14 (67; 46.5-86.8)2.0 (0.7-5.4).191.8 (0.6-5.4).59
At 6 months

YFS only (n=68)30 (44; 32.3-55.9)1.0N/AN/AN/A

YFS and infrequent app use (n=47)21 (45; 30.5-58.9)1.0 (0.5-2.2).950.8 (0.4-1.9).64

YFS and frequent app use (n=22)13 (59; 38.5-79.6)1.8 (0.7-4.8).221.8 (0.6-5.3).27

aPrEP: pre-exposure prophylaxis.

bAdjusted by gender identity (men who have sex with men vs transgender women), age at enrollment (15-17 vs 18-19) (years), number of sex in the past month at enrollment interviewed (0 vs 1 and ≥2), and self-perceived HIV acquisition risk at enrollment.

cUnadjusted odds ratio (95% CI) of adjusted variables in footnotea, as previously published [34].

dYFS: youth-friendly services.

eN/A: not applicable (reference).

The overall percentage of PrEP adherence was higher in frequent app users than in infrequent app users and the YFS arm, but this did not reach statistical significance. At month 6, the proportion of participants who achieved TFV-DP≥700 fmol/punch was 59% (13/22), 44% (30/68) among frequent app users, 45% (21/47) for infrequent users, and 44% (30/68) in the YFS arm (P=.47).

Exit Interview Findings

A total of 23 adolescents in the YFS+APP arm participated in exit interviews, of which 18 (78%) were YMSM and 20 (87%) were active PrEP users at the time of interview. Of all 23 participants interviewed, 3 (13%) had never logged in to the app, 17 (74%) were infrequent users, and 3 (13%) were frequent users. Interviews were conducted at a median (IQR) of 8.5 (5.0-12.4) months after completion of the study.

Reasons for app nonuse were categorized into those that were app-specific and those that were lifestyle-related. App-specific factors included the inconvenience of using a borrowed phone, requiring email verification during the registration process, finding app aesthetics and functions unengaging, and its lack of complete offline functionality. Lifestyle factors included changing phones, not loading the app onto their new phone, and being too busy with work and studies to use the app.

Regarding the risk assessment app feature, participants liked this feature the most because of the colorful graphics used in feeding back risk levels, because of not requiring the answering of too many questions, and also because it helped them to be more aware of their HIV risk. All 20 app user interviewees had used risk assessment features and reported that they performed risk assessments in the beginning and less later on for multiple reasons, including not being sexually active during the time, shift work, being busy with studies, forgetting to take their phone with them, or just forgetting to do the assessment.

Interviewees emphasized that for an app to be desirable for adolescents, it would need to be easy to use, feature attractive aesthetic features such as customizable color schemes and customizable avatars, and also provide the opportunity to interact with others. Privacy was also another major concern, and passcode protection and discreet branding of the app were also important. Although many participants expressed a desire for the app to have more information owing to its convenience and credibility, some felt that searching for information themselves on the web was easier and also provided the most up-to-date information. The app also needed to be competitive with other available apps, both health-related and nonhealth-related, in the market.

Reminders for Taking PrEP and Visit Reminders

Of the 87 app users, 45 (52%) used PrEP reminders and 34 (39%) clinic appointment reminders. Of the 45 participants who used PrEP reminders, 8 (18%) customized their reminder messages. Proportions of PrEP adherence observed between those who used and did not use the PrEP reminder function did not differ at month 3 (50% vs 68%; P=.13) or month 6 (50% vs 53%; P=.82).

Of the 20 app user exit interviewees, 15 (75%) reported using the PrEP reminder feature, and of the 15 reminder users, 8 (53%) liked the function because it helped them take PrEP on time. Moreover, 1 participant viewed this function as the most important feature of the app. Some interviewees who stopped using this function said they switched to using their phone alarm as it was more convenient, particularly in those using a borrowed study phone, as sometimes the app alarm did not go off as set.

Rewards and Redemption

Of the 87 app users, 51 (59%) accumulated sufficient points for cash redemption (range 100-504 points). Among the users, 49% (43/87) earned 100 to 199 points, 33% (29/87) earned 200 to 299 points, 16% (14/87) earned 300 to 399 points, and 2% (2/87) earned ≥400 points.

For redeeming prizes, exit interviewees, with 65% (13/20) of them having had participated in cash redemption, wanted the entire process to be automated (although accumulated points were visible in the app, redemption had to be done manually at clinic visits by study staff). The cash rewards used in this app were liked by 25% (5/20) of the app users, but many felt there was a need to increase variation in rewards with additional gimmicks, such as exchange of points for other prizes such as movie tickets and food vouchers. More importantly, to motivate the use of the app, the timing of reward redemption they felt should be earlier than at the 3- and 6-month clinic visits in this study.

Engagement With Site Staff Outside Monthly Clinic or Phone Call Visits

There were 578 interactions between study staff and 140 participants, with a median (IQR) of 4 (3-5) times per person. Engagement with staff was similar between the YFS (67/100, 67%) and YFS+APP (73/100, 73%) arms. Of the 578 interactions, 299 (51.7%) were initiated by clients. The median (IQR) time to first contact after enrollment was 6 (3-13) weeks. The topics of interactions included making appointments (128/299, 42.8%), relationships and personal issues (70/299, 23.4%), PrEP inquiries (54/299, 18.1%), HIV risk (29/299, 9.7%), and sexually transmitted disease diagnosis and management (18/299, 6%; Table 3).

Regarding what service aspects would keep them coming back, many felt this ultimately came down to staff being friendly, open, approachable, reliable, understanding, and holistic in their care.

Table 3. Topics of inquiry initiated by participants to site staff during 6 months of follow-up.
Contact topicsParticipants initiating contact (n=140a), n (%)bContacts (n=299), n (%)YFSc (n=149), n (%)YFS+APPd (n=150), n (%)P value
Clinic appointments90 (64.3)128 (42.8)64 (43)64 (42.7).96
Relationships and personal issues62 (37.1)70 (23.4)28 (18.8)42 (28).06
HIV PrEPe44 (31.4)54 (18.1)34 (22.8)20 (13.3).03
HIV risk acquisition26 (18.6)29 (9.7)14 (9.4)15 (10).86
Sexually transmitted diseases11 (7.8)18 (6)9 (6)9 (6).99

aTotal number of participants initiating contact.

bSome participants inquired more than once on >1 topic.

cYFS: youth-friendly services.

dYFS+APP: youth-friendly services plus mobile phone app.

ePrEP: pre-exposure prophylaxis.

Principal Findings

This randomized controlled study examined how a smartphone PrEP adherence support app used among adolescents in Thailand affected PrEP adherence and observed higher proportions of PrEP adherence among frequent app users than among infrequent users and the YFS arm at both months 3 and 6, although this did not reach statistical significance. To our knowledge, this study is one of the few studies that address key populations where a dearth of information exists in both young adolescents and low- and middle-income settings to inform future policy and practices in such settings [2,30,40]. Although some degree of success in using telehealth at public health levels in Thailand has been seen in some studies in Thailand, including the use of mobile phone SMS text messaging to support PrEP adherence [41], telephone-based drug adherence support for tuberculosis [42], web-based recruitment and linkage to home-based HIV testing [43], the use of mHealth technologies in HIV prevention efforts in Thailand and the Asia Pacific region is in its early stages, and few publications beyond preimplementation studies exist regarding mobile phone app implementation and effectiveness in risk behavior modification. The app produced and used in this trial was based on a behavioral change theory, IMB, where information provided on risk with self-assessments and motivation with reminders with medication alarms and point rewards.

Risk Assessment

Of the 87 participants, 22 (25%) were classified as frequent users, reflecting that app use was short-term in most users, which is consistent with a previous observation that 33% of users stop using their device in <6 months and 39% of commercial health apps were used ≤10 times before use was discontinued [44]. The lack of additional PrEP adherence benefit seen with mobile phone app use in this trial may have been due to dilution by the large proportion of infrequent app users and nonapp users in those randomized to use it. Given that it is known that, globally, mobile app retention, defined as the use of an app in the preceding 7 days, is only approximately 15%, the challenge of measuring real-world mobile phone app effectiveness could be addressed with larger trials to establish whether this short duration of use is sufficient to elicit behavioral change or whether strategies are needed to encourage longer use to enable behavioral change [45]. It is also important to consider whether app use is able to elicit behavioral change, specifically by what mechanism, which could be done by isolation and testing of individual components to allow future innovations to build upon in developing effective strategies, currently a research gap in mHealth technologies [32,44,46]. Improvement of aesthetics and ensuring features were customizable, having more options for cash reward exchanges, having more social interaction, and more health information were also major themes that arose in the exit interviews as areas in which users felt the app could be improved to increase user engagement. This is consistent with a previous review of mobile phone app use in HIV prevention that app inclusiveness and interactivity are more likely to attract and retain users as well as elicit behavioral change [45].

Individuals may have felt no need to continue performing self-risk assessments if they intended to continue the same preventive measures. Those who continued with LRA may have been those who had fluctuations in sexual HIV risk behaviors, the worried well, or point reward collectors. Many exit interviewees said that the action of assessment was a reminder to consider self-risk, which in turn influenced planned health behaviors. We feel this self-acknowledgment of one’s true risk level was supported by the app, which enabled privacy and discrete assessment and bypassed the need for human interaction and potential judgmental attitudes faced in making this assessment. In addition, users were able to try inputting data relevant to different scenarios, as it was possible to repeat assessments in planning upcoming sexual encounters. We think that the large drop-off of users toward the end of the trial is reflective of findings from previous studies that apps are mainly effective in those who are already motivated but are less effective at supporting user capabilities and maintaining behavioral changes [46].

On the basis of the exit interview findings, the Raincoat app was found to be easy to use. App design allowing ease of utility clearly influenced how likely participants would use the app. This observation is in keeping with previous studies that found simple interfaces may reduce the time participants need to spend on the app and therefore improve retention [30].


Over half of the app users used their PrEP reminder function. Our exit interviews found that many users felt that the function was very useful for supporting PrEP adherence. Tailored, short pieces of information on self-risk fed back at weekly intervals used in this trial has been reported to be the preferred mode of messaging in other studies compared with general health information [46]. However, in this study, no association was observed between medication alarm use and PrEP adherence, suggesting that this feature alone may not support PrEP adherence for all users. Furthermore, given that only 18% (8/45) of participants customized their reminder message function, it could be argued that this is a nonessential feature for future versions. All those interviewed said that the alarm function did not always work in this trial was a barrier to their engagement with it. This study highlighted the implementation of mHealth technologies, particularly in low- and middle-income settings. Plans and budget allocations must be made for the technical maintenance of their functionality to ensure engagement and maximum benefit of use over time. It should also be noted that some participants switched to using their own phone alarm for medication reminders, suggesting that the alarm function may not be an essential in-app feature for adolescents, particularly in resource-limited settings.

Rewards and Redemption

In this study, we observed that cash rewards may not be sufficient on their own to influence health behaviors, which is consistent with a previous review that suggested, at best, conditional economic incentives can be a valuable part of but cannot replace other HIV prevention approaches and, importantly, need to be adapted to specific contexts and populations for maximal success [47]. This would need to be carefully experimentally isolated to explore this possibility further [48].

Engagement With Site Staff

Engagement in this study at monthly scheduled visits or phone calls plus optional additional staff consultation producing a 73% retention rate may have reduced the impact of receiving the app intervention seen, given that it is known that 2-way interaction between providers and clients is known to improve medication adherence [2]. Appointment-related queries made up nearly half of all contact topics in both study arms and accounted for 64.3% (90/140) of all participants who initiated contact. This strongly suggests that an automated system in the app to book and confirm appointments would improve convenience for both service users and providers. Relationships and personal issues and PrEP-related queries also made up approximately one-fifth each of queries to staff, suggesting that specific in-app information provision and staff training on these issues may benefit service users. These data highlight the unique considerations to be made in adolescent and young adult HIV prevention service provision to address developmental needs to support their decision-making, establishment of identity, interpersonal challenges, and mental health issues commonly seen at this stage of life [27].

Types of Clinic Settings or Services

Although the intervention of interest was a mobile phone app, it must be acknowledged that the contexts in which this study occurred were medical center–based facilities with HIV expertise or community-based organizations (CBOs), both of which are unique to general PrEP provision services available in Thailand. All the locations used in this study have study staff with training on the same basis to deliver the intervention and a focus of work on HIV prevention and client-centered care, with medical center–based facilities having the strength of delivering the intervention directly and CBOs having the advantage of key population-led care, which, as has been seen in other studies, supported PrEP adherence and retention in services well [20,49]. It is possible that such differences could have acted as effect modifiers in the interventions studied. General PrEP services in Thailand are delivered at medical center–based facilities with a larger variety of health issues and have a larger volume of service users, making holistic health care much more challenging to deliver. Medical centers and CBOs may draw different types of populations, and with randomization, the characteristics are balanced between the 2 arms. The heterogeneity of the sample makes the generalizability of the study results to broader populations.

It is also recognized that mHealth has greatly facilitated the maintenance of some health care delivery services in the last year during the COVID-19 pandemic [50-53]. Evidence suggests that HIV at-risk populations globally, including YMSM and YTGW, have faced considerable health care access disruptions and urgent development and implementation of telehealth as part of efforts to minimize such disruptions, in addition to other policy level initiatives, will minimize associated care disruption-related HIV morbidity and mortality [54,55]. The largest PrEP provider of Thailand, the Princess PrEP Program, has recognized since its initiation in 2016 that service users require adherence and retention support, particularly in TGW, which could be supported using mHealth technologies [21].


Although the original design of this study was fully powered to compare those who received YFS versus YFS+APP, as a significant proportion of study participants infrequently used the app, it became necessary for the final analysis to stratify outcome groups into frequent users (LRA10) and infrequent users (LRA<10). The actual analysis was therefore not fully powered; thus, results from this study should be viewed as preliminary as part of a pilot randomized control trial. Another limitation of this study was that the app used for the intervention in this study was based on just 2 FGDs, which may have provided an inadequate range of views in the design of the app. In addition, the protocol of this study was designed to describe the natural history of app use without any formal encouragement from the study team. App paradata were therefore collated at the end of study for this analysis. However, another possible policy that could have been taken was to continually look at app use and discuss app use obstacles at each contact to rapidly assess and address functionality problems and also to collect design issues real time when these issues are fresh in the minds of the users and more likely to be recalled more clearly. In addition, given that the efficacy of mobile technologies is also linked to literacy and the performance of this study in a large city, findings from it may not apply to a more rural area where access to mobile technologies and literacy may be more challenging and less benefit gained from such a form of service provision enhancement, a limitation of mHealth seen previously [44]. Only a total of 6 interviewees participated in FGDs that informed the design of this app, which may have affected the generalizability of the preference representation drawn from this sample of adolescents. The sampling frame used for exit interviews in this study was also biased toward those who were classified as frequent users of the app, which may have led to findings being more biased toward favoring app functions. Given no differences were seen between arms, interviews with control arm participants could have been done to provide further information on possible reasons for this. Interviews in this study were conducted for quite a long time after study completion in most cases, which may have led to limited data quality owing to implications on participant recall. The small sample size of this study also limits the generalizability of the conclusions drawn from this study, and it is possible that the intervention was not efficacious or the sample size was too small to see any effect present.


Using a target population-informed design for a mobile phone app supporting PrEP adherence in an adolescent PrEP implementation study, we observed higher rates of PrEP adherence among those who frequently used the app, although the difference was not statistically significant. App use dropped by 50% by week 6, suggesting its possible usefulness in establishing habits but not for long-term adherence maintenance. Further studies on specific mechanisms in which mobile apps are effective in influencing health behaviors are needed to inform future mHealth scale-up operations, particularly in low- and middle-income settings with limited staff service capacity. mHealth development and implementation will ultimately benefit health access and delivery for HIV prevention services beyond its current apps in the current COVID-19 pandemic.


The authors would like to acknowledge members of the Center of Excellence for Pediatric Infectious Diseases and Vaccines—Institute of HIV Research and Innovation Adolescent Study Team: Praphan Phanuphak, Chitsanu Pancharoen, Somsong Teeratakulpisarn, Reshmie Ramautarsing, Rena Janamnuaysook, Kritima Samitpol, Jiratchaya Kongkapan, Artsanee Chancham, Pravit Mingkwanrungruang, Narukjaporn Thammajaruk, Nuttawut Teachatanawat, Krittaporn Termvanich, Tippawan Pankam, Thantip Sungsing, Sorawit Amatavete, Chotika Prabjantuek, Phubet Panpet, Jureeporn Jantarapakde, Tuangtip Theerawit, Watsamon Jantarabenjakul, Suvaporn Anugulruengkitt, Nattapong Jitrunruengnit, Noppadol Wacharachaisurapol, Pintip Suchartlikitwong, Pakpoom Janewongwirot, Krittaporn Pornpaisalsakul, Juthamanee Moonwong, Rachaneekorn Nadsasarn, Patchareeyawan Srimuan, Siwanart Thammasala, Sasiwimol Ubolyam, Patcharin Eamyoung, Jiratchaya Sophonphan, Stephen Kerr, Taninee Petwijit, Chansuda Bongsebandhu-phubakdi, Buajoom Raksakul, Pathranis Meekrua, Orawan Fungfoosri, Prapaipan Plodgratoke, Pakitta Kidsumret, Kamolchanok Chumyen, Sahakun Chintanakarn, Sirinthon Yenjit, Chanin Suksom, Tanunjit Rugphan, Somsri Tantipaibulvut, Prakaipech Kaw-In, Penprapa Chanachon, Chanjiraporn Pondet.

The authors also thank Pathomchai Amornratpaijit from the Center of Excellence for Pediatric Infectious Diseases and Vaccines for his support in finance and administrative management; Focal Intelligence Co. Ltd team members Rachapong Pornwiriyangkura, Mathawee Tusjunt, Patcharamon Siriphongpiphat, Rawisara Loekiatthamrong, and Sitthiphong Achavan for their support in designing and producing Project Raincoat; Yardpiroon Tawon for her hard work in supporting tenofovir diphosphate assay analyses; Dr Sara LeGrand and Shashika Bandara of Duke University for their support in conducting the Chulalongkorn University mHealth training and support in writing this manuscript; and Dr. Arunrat Tangmunkongvorakul of Chiang Mai University for her support in conducting qualitative study capacity training for the study staff.

CIPHER (Collaborative Initiative for Pediatric HIV Education and Research; grant 2017/472-SON) provided core funding for this study. The medication and medical care provided through the Princess PrEP Program was supported by the US President’s Emergency Plan for AIDS Relief and the US Agency for International Development through the Linkages Across the Continuum of HIV Services for Key Populations Cooperative Agreement (grant AID-OAA-A-14-0045) managed by FHI 360. The Ratchadapisek Sompoch Endowment Fund (2019-2020) under Telehealth Cluster, Chulalongkorn University, provided supplemental mHealth Research Funding Support and also funding for mHealth staff capacity building, The Chulalongkorn University C2F Postdoctoral Fellowship Fund supported SK, and The Chulalongkorn University Ratchadapisek Sompoch Postdoctoral Fellowship Fund (2019-2020) supported WNS.

Conflicts of Interest

None declared.

Multimedia Appendix 1

CONSORT eHEALTH Checklist (V 1.6.1).

PDF File (Adobe PDF File), 175 KB

  1. Nguyen LH, Tran BX, Rocha LE, Nguyen HL, Yang C, Latkin CA, et al. A systematic review of eHealth interventions addressing HIV/STI prevention among men who have sex with men. AIDS Behav 2019 Sep;23(9):2253-2272 [FREE Full text] [CrossRef] [Medline]
  2. Henny KD, Wilkes AL, McDonald CM, Denson DJ, Neumann MS. A rapid review of eHealth interventions addressing the continuum of HIV care (2007-2017). AIDS Behav 2018 Jan;22(1):43-63 [FREE Full text] [CrossRef] [Medline]
  3. WHO Global Observatory for eHealth. mHealth: New Horizons for Health Through Mobile Technologies: Second Global Survey on eHealth. Geneva: World Health Organization; 2011.
  4. Couper MP, Alexander GL, Zhang N, Little RJ, Maddy N, Nowak MA, et al. Engagement and retention: measuring breadth and depth of participant use of an online intervention. J Med Internet Res 2010;12(4):e52 [FREE Full text] [CrossRef] [Medline]
  5. Topics: key populations. UNAIDS. 2020.   URL: [accessed 2022-01-07]
  6. van Griensven F, Guadamuz TE, de Lind van Wijngaarden JW, Phanuphak N, Solomon SS, Lo Y. Challenges and emerging opportunities for the HIV prevention, treatment and care cascade in men who have sex with men in Asia Pacific. Sex Transm Infect 2017 Aug;93(5):356-362. [CrossRef] [Medline]
  7. van Griensven F, Thienkrua W, McNicholl J, Wimonsate W, Chaikummao S, Chonwattana W, et al. Evidence of an explosive epidemic of HIV infection in a cohort of men who have sex with men in Thailand. AIDS 2013 Mar 13;27(5):825-832. [CrossRef] [Medline]
  8. Idele P, Gillespie A, Porth T, Suzuki C, Mahy M, Kasedde S, et al. Epidemiology of HIV and AIDS among adolescents: current status, inequities, and data gaps. J Acquir Immune Defic Syndr 2014 Jul 01;66 Suppl 2:144-153. [CrossRef] [Medline]
  9. Thienkrua W, van Griensven F, Mock PA, Dunne EF, Raengsakulrach B, Wimonsate W, et al. Young men who have sex with men at high risk for HIV, Bangkok MSM cohort study, Thailand 2006-2014. AIDS Behav 2018 Jul 14;22(7):2137-2146 [FREE Full text] [CrossRef] [Medline]
  10. van Griensven F, Varangrat A, Wimonsate W, Tanpradech S, Kladsawad K, Chemnasiri T, et al. Trends in HIV prevalence, estimated HIV incidence, and risk behavior among men who have sex with men in Bangkok, Thailand, 2003–2007. J Acquir Immune Defic Syndr 2010 Feb;53(2):234-239. [CrossRef] [Medline]
  11. HIV Surveillance Report, 2018 (Updated). Centers for Disease Control and Prevention. 2020.   URL: [accessed 2022-01-17]
  12. Wasantioopapokakorn M, Manopaiboon C, Phoorisri T, Sukkul A, Lertpiriyasuwat C, Ongwandee S, et al. Implementation and assessment of a model to increase HIV testing among men who have sex with men and transgender women in Thailand, 2011-2016. AIDS Care 2018 Oct;30(10):1239-1245 [FREE Full text] [CrossRef] [Medline]
  13. Colby D, Nguyen NA, Le B, Toan T, Thien DD, Huyen HT, et al. HIV and Syphilis prevalence among transgender women in Ho Chi Minh City, Vietnam. AIDS Behav 2016 Dec;20(Suppl 3):379-385. [CrossRef] [Medline]
  14. Policy brief: pre-exposure prophylaxis (PrEP): WHO expands recommendation on oral pre-exposure prophylaxis of HIV infection (PrEP). Document number WHO/HIV/2015.48. World Health Organization. 2015.   URL: [accessed 2022-01-20]
  15. Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 2010 Dec 30;363(27):2587-2599 [FREE Full text] [CrossRef] [Medline]
  16. Hodges-Mameletzis I, Dalal S, Msimanga-Radebe B, Rodolph M, Baggaley R. Going global: the adoption of the World Health Organization’s enabling recommendation on oral pre-exposure prophylaxis for HIV. Sex Health 2018;15(6):489. [CrossRef]
  17. McCormack S, Dunn DT, Desai M, Dolling DI, Gafos M, Gilson R, et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet 2016 Jan 2;387(10013):53-60 [FREE Full text] [CrossRef] [Medline]
  18. Molina J, Capitant C, Spire B, Pialoux G, Cotte L, Charreau I, et al. On-demand preexposure prophylaxis in men at high risk for HIV-1 infection. N Engl J Med 2015 Dec 3;373(23):2237-2246. [CrossRef] [Medline]
  19. Manosuthi W, Ongwandee S, Bhakeecheep S, Leechawengwongs M, Ruxrungtham K, Phanuphak P, Adults and Adolescents Committee of the Thai National HIV Guidelines Working Group. Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents 2014, Thailand. AIDS Res Ther 2015;12:12 [FREE Full text] [CrossRef] [Medline]
  20. Phanuphak N, Sungsing T, Jantarapakde J, Pengnonyang S, Trachunthong D, Mingkwanrungruang P, et al. Princess PrEP program: the first key population-led model to deliver pre-exposure prophylaxis to key populations by key populations in Thailand. Sex Health 2018 Nov;15(6):542-555. [CrossRef] [Medline]
  21. Ramautarsing RA, Meksena R, Sungsing T, Chinbunchorn T, Sangprasert T, Fungfoosri O, et al. Evaluation of a pre-exposure prophylaxis programme for men who have sex with men and transgender women in Thailand: learning through the HIV prevention cascade lens. J Int AIDS Soc 2020 Jun;23 Suppl 3:e25540 [FREE Full text] [CrossRef] [Medline]
  22. Suraratdecha C, Stuart RM, Manopaiboon C, Green D, Lertpiriyasuwat C, Wilson DP, et al. Cost and cost-effectiveness analysis of pre-exposure prophylaxis among men who have sex with men in two hospitals in Thailand. J Int AIDS Soc 2018 Jul 22;21 Suppl 5:e25129 [FREE Full text] [CrossRef] [Medline]
  23. Grant RM, Anderson PL, McMahan V, Liu A, Amico KR, Mehrotra M, et al. Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study. Lancet Infect Dis 2014 Sep;14(9):820-829. [CrossRef] [Medline]
  24. Mullins TL, Lehmann CE. Oral Pre-Exposure Prophylaxis (PrEP) for HIV prevention in adolescents and young adults. Curr Pediatr Rep 2018 Jun;6(2):114-122 [FREE Full text] [CrossRef] [Medline]
  25. Hosek SG, Landovitz RJ, Kapogiannis B, Siberry GK, Rudy B, Rutledge B, et al. Safety and feasibility of antiretroviral preexposure prophylaxis for adolescent men who have sex with men aged 15 to 17 years in the United States. JAMA Pediatr 2017 Nov 01;171(11):1063-1071. [CrossRef] [Medline]
  26. Hosek SG, Rudy B, Landovitz R, Kapogiannis B, Siberry G, Rutledge B, Adolescent Trials Network (ATN) for HIVAIDS Interventions. An HIV preexposure prophylaxis demonstration project and safety study for young MSM. J Acquir Immune Defic Syndr 2017 Jan 01;74(1):21-29. [CrossRef] [Medline]
  27. Hosek S, Pettifor A. HIV prevention interventions for adolescents. Curr HIV/AIDS Rep 2019 Feb;16(1):120-128 [FREE Full text] [CrossRef] [Medline]
  28. Seekaew P, Nguyen E, Sungsing T, Jantarapakde J, Pengnonyang S, Trachunthong D, et al. Correlates of nonadherence to key population-led HIV pre-exposure prophylaxis services among Thai men who have sex with men and transgender women. BMC Public Health 2019 Mar 21;19(1):328 [FREE Full text] [CrossRef] [Medline]
  29. Badawy SM, Barrera L, Sinno MG, Kaviany S, O'Dwyer LC, Kuhns LM. Text messaging and mobile phone apps as interventions to improve adherence in adolescents with chronic health conditions: a systematic review. JMIR Mhealth Uhealth 2017 May 15;5(5):e66 [FREE Full text] [CrossRef] [Medline]
  30. Zhao J, Freeman B, Li M. Can mobile phone apps influence people's health behavior change? An evidence review. J Med Internet Res 2016 Oct 31;18(11):e287 [FREE Full text] [CrossRef] [Medline]
  31. Fuchs JD, Stojanovski K, Vittinghoff E, McMahan VM, Hosek SG, Amico KR, et al. A mobile health strategy to support adherence to antiretroviral preexposure prophylaxis. AIDS Patient Care STDS 2018 Mar;32(3):104-111 [FREE Full text] [CrossRef] [Medline]
  32. Maloney KM, Bratcher A, Wilkerson R, Sullivan PS. Electronic and other new media technology interventions for HIV care and prevention: a systematic review. J Int AIDS Soc 2020 Jan;23(1):e25439 [FREE Full text] [CrossRef] [Medline]
  33. Fisher WA, Fisher JD, Harman J. The information-motivation-behavioral skills model: a general social psychological approach to understanding and promoting health behavior. In: Social Psychological Foundations of Health and Illness. Hoboken, New Jersey, United States: John Wiley & Sons; 2003:82-106.
  34. Songtaweesin WN, Kawichai S, Phanuphak N, Cressey TR, Wongharn P, Saisaengjan C, CE-PID - TRC Adolescent Study Team. Youth-friendly services and a mobile phone application to promote adherence to pre-exposure prophylaxis among adolescent men who have sex with men and transgender women at-risk for HIV in Thailand: a randomized control trial. J Int AIDS Soc 2020 Sep;23 Suppl 5:e25564 [FREE Full text] [CrossRef] [Medline]
  35. Miller WR, Rollnick S. Meeting in the middle: motivational interviewing and self-determination theory. Int J Behav Nutr Phys Act 2012;9:25 [FREE Full text] [CrossRef] [Medline]
  36. Palacio A, Garay D, Langer B, Taylor J, Wood BA, Tamariz L. Motivational interviewing improves medication adherence: a systematic review and meta-analysis. J Gen Intern Med 2016 Aug;31(8):929-940. [CrossRef] [Medline]
  37. Aliabadi N, Carballo-Dieguez A, Bakken S, Rojas M, Brown W, Carry M, et al. Using the information-motivation-behavioral skills model to guide the development of an HIV prevention smartphone application for high-risk MSM. AIDS Educ Prev 2015 Dec;27(6):522-537. [CrossRef] [Medline]
  38. Hawkins RP, Kreuter M, Resnicow K, Fishbein M, Dijkstra A. Understanding tailoring in communicating about health. Health Educ Res 2008 Jun;23(3):454-466 [FREE Full text] [CrossRef] [Medline]
  39. Anderson PL, Liu AY, Castillo-Mancilla JR, Gardner EM, Seifert SM, McHugh C, et al. Intracellular tenofovir-diphosphate and emtricitabine-triphosphate in dried blood spots following directly observed therapy. Antimicrob Agents Chemother 2018 Jan;62(1) [FREE Full text] [CrossRef] [Medline]
  40. Kapogiannis BG, Nelson RM, Siberry GK, Lee S, Hazra R. Advancing HIV biomedical prevention research for at-risk adolescents. J Acquir Immune Defic Syndr 2018 Dec 15;79(5):535-542 [FREE Full text] [CrossRef] [Medline]
  41. Brown W, Giguere R, Sheinfil A, Ibitoye M, Balan I, Ho T, et al. Challenges and solutions implementing an SMS text message-based survey CASI and adherence reminders in an international biomedical HIV PrEP study (MTN 017). J Biomed Inform 2018 Apr;80:78-86 [FREE Full text] [CrossRef] [Medline]
  42. Ratchakit-Nedsuwan R, Nedsuwan S, Sawadna V, Chaiyasirinroje B, Bupachat S, Ngamwithayapong-Yanai J, et al. Ensuring tuberculosis treatment adherence with a mobile-based CARE-call system in Thailand: a pilot study. Infect Dis (Lond) 2020 Feb;52(2):121-129. [CrossRef] [Medline]
  43. Phanuphak N, Anand T, Jantarapakde J, Nitpolprasert C, Himmad K, Sungsing T, et al. What would you choose: online or offline or mixed services? Feasibility of online HIV counselling and testing among Thai men who have sex with men and transgender women and factors associated with service uptake. J Int AIDS Soc 2018 Jul;21 Suppl 5:e25118 [FREE Full text] [CrossRef] [Medline]
  44. Cambon L. Health smart devices and applications…towards a new model of prevention? Eur J Public Health 2017;27(3):390-391. [CrossRef]
  45. Muessig KE, Pike EC, Legrand S, Hightow-Weidman LB. Mobile phone applications for the care and prevention of HIV and other sexually transmitted diseases: a review. J Med Internet Res 2013;15(1):e1 [FREE Full text] [CrossRef] [Medline]
  46. Aromatario O, Van Hoye A, Vuillemin A, Foucaut AM, Crozet C, Pommier J, et al. How do mobile health applications support behaviour changes? A scoping review of mobile health applications relating to physical activity and eating behaviours. Public Health 2019 Oct;175:8-18 [FREE Full text] [CrossRef] [Medline]
  47. Operario D, Kuo C, Sosa-Rubí SG, Gálarraga O. Conditional economic incentives for reducing HIV risk behaviors: integration of psychology and behavioral economics. Health Psychol 2013 Sep;32(9):932-940 [FREE Full text] [CrossRef] [Medline]
  48. Vlaev I, King D, Darzi A, Dolan P. Changing health behaviors using financial incentives: a review from behavioral economics. BMC Public Health 2019 Aug 07;19(1):1059 [FREE Full text] [CrossRef] [Medline]
  49. Ochonye B, Folayan MO, Fatusi AO, Emmanuel G, Adepoju O, Ajidagba B, et al. Satisfaction with use of public health and peer-led facilities for HIV prevention services by key populations in Nigeria. BMC Health Serv Res 2019 Nov 21;19(1):856 [FREE Full text] [CrossRef] [Medline]
  50. Iyengar K, Upadhyaya GK, Vaishya R, Jain V. COVID-19 and applications of smartphone technology in the current pandemic. Diabetes Metab Syndr 2020;14(5):733-737 [FREE Full text] [CrossRef] [Medline]
  51. Ming LC, Untong N, Aliudin NA, Osili N, Kifli N, Tan CS, et al. Mobile health apps on COVID-19 launched in the early days of the pandemic: content analysis and review. JMIR Mhealth Uhealth 2020 Sep 16;8(9):e19796 [FREE Full text] [CrossRef] [Medline]
  52. Lesko CR, Bengtson AM. HIV and COVID-19: intersecting epidemics with many unknowns. Am J Epidemiol 2021 Jan 04;190(1):10-16 [FREE Full text] [CrossRef] [Medline]
  53. Hoagland B, Torres TS, Bezerra DR, Geraldo K, Pimenta C, Veloso VG, et al. Telemedicine as a tool for PrEP delivery during the COVID-19 pandemic in a large HIV prevention service in Rio de Janeiro-Brazil. Braz J Infect Dis 2020 May 31 [FREE Full text] [CrossRef] [Medline]
  54. Sun Y, Li H, Luo G, Meng X, Guo W, Fitzpatrick T, et al. Antiretroviral treatment interruption among people living with HIV during COVID-19 outbreak in China: a nationwide cross-sectional study. J Int AIDS Soc 2020 Nov;23(11):e25637 [FREE Full text] [CrossRef] [Medline]
  55. Rao A, Rucinski K, Jarrett BA, Ackerman B, Wallach S, Marcus J, et al. Perceived interruptions to HIV prevention and treatment services associated with COVID-19 for gay, bisexual, and other men who have sex with men in 20 countries. J Acquir Immune Defic Syndr 2021 May 01;87(1):644-651. [CrossRef] [Medline]

CBO: community-based organization
CIPHER: Collaborative Initiative for Pediatric HIV Education and Research
DBS: dried blood spot
FGD: focus group discussion
IMB: information–motivation–behavioral
LRA: log-in and risk assessment
MSM: men who have sex with men
PrEP: pre-exposure prophylaxis
RSAT: Rainbow Sky Association of Thailand
SWING: Service Workers in Group
TFV-DP: tenofovir diphosphate
TGW: transgender women
TRCARC: Thai Red Cross AIDS Research Center
YFS: youth-friendly services
YFS+APP: youth-friendly services plus mobile phone app
YMSM: young men who have sex with men
YTGW: young transgender women

Edited by L Buis; submitted 07.11.20; peer-reviewed by A Queiroz, J Jones; comments to author 17.12.20; revised version received 11.02.21; accepted 09.12.21; published 21.04.22


©Surinda Kawichai, Wipaporn Natalie Songtaweesin, Prissana Wongharn, Nittaya Phanuphak, Tim R Cressey, Juthamanee Moonwong, Anuchit Vasinonta, Chutima Saisaengjan, Tanat Chinbunchorn, Thanyawee Puthanakit. Originally published in JMIR mHealth and uHealth (, 21.04.2022.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR mHealth and uHealth, is properly cited. The complete bibliographic information, a link to the original publication on, as well as this copyright and license information must be included.